Baring buys Japan’s Bushu Pharma for $670m

The fund agreed to buy the contract drug maker from Tokio Marine Capital, the largest private equity deal in Japan’s healthcare sector this year.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES